Study of the Therapeutic Vaccine (ISA101/ISA101b) to Treat Advanced or Recurrent Cervical Cancer
Clinical trial NCT02128126 · COMPLETED
Trial details
- NCT number
- NCT02128126
- Sponsor
- ISA Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-01
- Primary completion
- 2018-08-01
- Enrollment
- 93
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.